<span item_type="fundamental" item_id="4d2f9202d51fb66bf12248cdace8baa8" counter_id="ST/US/PRKR" env="prod"></span><span item_type="announcement" item_id="548717971309987201" env="prod"></span><p>Revenue: As of FY2025 Q2, the actual value is USD 0.</p><p>EPS: As of FY2025 Q2, the actual value is USD -0.01.</p><p></p><h3>Net Loss</h3><p>ParkerVision reported a net loss for the second quarter of 2025 of $1.6 million, or $0.01 per common share, compared to a net loss of $0.3 million, or $0.00 per common share for the second quarter of 2024. On a year-to-date basis, the Company reported a net loss for the first six months of 2025 of $5.4 million, or $0.05 per common share, compared to a net loss of $1.0 million, or $0.01 per common share for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925026190/ex_829677.htm"></span></p><h3>Operating Expenses</h3><p>The increase in net loss for the three months ended June 30, 2025, when compared to the three months ended June 30, 2024, is primarily the result of a $3.2 million increase in operating expenses, offset by a $1.8 million increase in the gain recognized from decreases in the estimated fair value of the Company’s contingent payment obligations. The increase in net loss for the six months ended June 30, 2025, when compared to the six months ended June 30, 2024, is primarily the result of a $3.6 million increase in operating expenses along with a $0.9 million change in the estimated fair value of the Company’s contingent payment obligations.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925026190/ex_829677.htm"></span></p><h3>Cash Flow</h3><p>The Company used approximately $3.0 million in cash for operations for the first six months of 2025 and ended the quarter with $2.05 million in cash and cash equivalents.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925026190/ex_829677.htm"></span></p><h3>Balance Sheet Highlights</h3><ul><li>Cash and cash equivalents: $2.05 million as of June 30, 2025, compared to $4.92 million as of December 31, 2024.</li><li>Total assets: $3.07 million as of June 30, 2025, compared to $5.88 million as of December 31, 2024.</li><li>Current liabilities: $2.46 million as of June 30, 2025, compared to $2.41 million as of December 31, 2024.</li><li>Contingent payment obligations: $46.82 million as of June 30, 2025, compared to $46.66 million as of December 31, 2024.</li><li>Convertible notes, net of current portion: $2.01 million as of June 30, 2025, compared to $3.02 million as of December 31, 2024.</li><li>Shareholders’ deficit: - $48.34 million as of June 30, 2025, compared to - $46.41 million as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925026190/ex_829677.htm"></span></li></ul><h3>Summary of Cash Flows</h3><ul><li>Net cash used in operating activities: - $2.97 million for the six months ended June 30, 2025, compared to - $1.42 million for the same period in 2024.</li><li>Net cash used in investing activities: - $43 thousand for the six months ended June 30, 2025, compared to $0 for the same period in 2024.</li><li>Net cash provided by (used in) financing activities: $142 thousand for the six months ended June 30, 2025, compared to - $117 thousand for the same period in 2024.</li><li>Net decrease in cash and cash equivalents: - $2.87 million for the six months ended June 30, 2025, compared to - $1.54 million for the same period in 2024.</li><li>Cash and cash equivalents at the beginning of the period: $4.92 million for the six months ended June 30, 2025, compared to $2.56 million for the same period in 2024.</li><li>Cash and cash equivalents at the end of the period: $2.05 million for the six months ended June 30, 2025, compared to $1.03 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925026190/ex_829677.htm"></span></li></ul><h3>Outlook / Guidance</h3><p>ParkerVision continues to focus on its Texas actions, including the Realtek case, which is scheduled for trial in January 2026. The company remains hopeful that the court will rule in its favor regarding the receiver claims in the Qualcomm case, providing a path to an efficient resolution. ParkerVision is working to raise awareness of the essential role innovators play in driving technological leadership and national security for the United States.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925026190/ex_829677.htm"></span></p>

ParkerVision, Inc. | 8-K: FY2025 Q2 Revenue: USD 0